Brief: Corline Biomedical Q1 Pre-tax Loss Narrows To SEK 2.5 Mln
May 12 (Reuters) - Corline Biomedical AB CLBIO.ST :
* Q1 NET SALES SEK 191,000 VERSUS SEK 140,000 YEAR AGO
* Q1 PRE-TAX LOSS SEK 2.5 MILLION VERSUS LOSS SEK 3.0
MILLION YEAR
AGO
Source text for Eikon: ID:nGNE4rC8W9
Further company coverage: CLBIO.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Corline Biomedical AB
See all newsBrief: Corline Biomedical Expectes Positive EBITDA In 2027
Brief: Corline Biomedical: Canada To Grant Kardium Up To C$31.25 Mln For Manufacturing Capacity Expansion
Brief: Corline Biomedical Q2 Net Sales Amount To SEK 4.7 Million
Brief: Corline Biomedical Partner Kardium Receives Approval For Globe Pulsed Field System In Canada
Brief: Corline Biomedical Q1 Result After Financial Items At SEK -2.5 Mln